Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangyabao is a Traditional Chinese Medicine (TCM) formulation developed and utilized by the Henan Provincial Traditional Chinese Medicine Research Institute for the treatment of hypertensive disease (hypertension). As a TCM product, it typically consists of a combination of herbal extracts designed to regulate blood pressure and alleviate associated symptoms such as dizziness and headaches. It has been the subject of evidence-based medicine research using clinical data (CPOE mode) to evaluate its efficacy and safety in real-world clinical settings. In China, such formulations are often managed as hospital preparations (医院制剂), which are approved for use within specific medical institutions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiangyabao.